跳到正文
原文
Endpoints News 生物医药· Reynald Castaneda·· 9 天前AI 评分40

Merck KGaA 获 FDA 批准其从 Abbisko 许可的肿瘤药物用于罕见非癌性肿瘤

Merck KGaA lands FDA nod for joint tumor drug it licensed from Abbisko

AI 导读

Merck KGaA 获得 FDA 批准,其从中国生物技术公司 Abbisko 许可的药物可用于治疗罕见非癌性肿瘤。

正文

Mer­ck KGaA said Tues­day that the drug it li­censed from a Chi­na-based biotech has se­cured FDA ap­proval for rare non­cancer­ous tu­mors …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news